Nanjing Financial Statements From 2010 to 2025
| 688273 Stock | 31.41 1.54 5.16% |
Check Nanjing Medlander financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nanjing Medlander's main balance sheet or income statement drivers, such as , as well as many indicators such as . Nanjing financial statements analysis is a perfect complement when working with Nanjing Medlander Valuation or Volatility modules.
Nanjing |
Nanjing Medlander Medical Company Current Valuation Analysis
Nanjing Medlander's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Nanjing Medlander Current Valuation | 2.24 B |
Most of Nanjing Medlander's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nanjing Medlander Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Nanjing Medlander Medical has a Current Valuation of 2.24 B. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The current valuation for all China stocks is notably lower than that of the firm.
Nanjing Medlander Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nanjing Medlander's current stock value. Our valuation model uses many indicators to compare Nanjing Medlander value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nanjing Medlander competition to find correlations between indicators driving Nanjing Medlander's intrinsic value. More Info.Nanjing Medlander Medical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.51 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Nanjing Medlander Medical is roughly 1.95 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nanjing Medlander by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nanjing Medlander's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Nanjing Medlander Financial Statements
Nanjing Medlander stakeholders use historical fundamental indicators, such as Nanjing Medlander's revenue or net income, to determine how well the company is positioned to perform in the future. Although Nanjing Medlander investors may analyze each financial statement separately, they are all interrelated. For example, changes in Nanjing Medlander's assets and liabilities are reflected in the revenues and expenses on Nanjing Medlander's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Nanjing Medlander Medical. Please read more on our technical analysis and fundamental analysis pages.
Currently Active Assets on Macroaxis
Other Information on Investing in Nanjing Stock
Nanjing Medlander financial ratios help investors to determine whether Nanjing Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanjing with respect to the benefits of owning Nanjing Medlander security.